Stem Cell Sciences Appoints Alastair Riddell as CEO

Stem Cell Sciences plc (SCS, AIM:STEM, ASX: STC), the global biotechnology company focused on the commercialisation of stem cells and stem cell technologies in research and cell-based therapies, announces today the appointment of Dr Alastair James Riddell, aged 58, as Chief Executive Officer (CEO).

Source: Stem Cell Sciences